Cargando…

Examining patterns of multimorbidity, polypharmacy and risk of adverse drug reactions in chronic obstructive pulmonary disease: a cross-sectional UK Biobank study

OBJECTIVE: This study aims: (1) to describe the pattern and extent of multimorbidity and polypharmacy in UK Biobank participants with chronic obstructive pulmonary disease (COPD) and (2) to identify which comorbidities are associated with increased risk of adverse drug reactions (ADRs) resulting fro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hanlon, Peter, Nicholl, Barbara I, Jani, Bhautesh Dinesh, McQueenie, Ross, Lee, Duncan, Gallacher, Katie I, Mair, Frances S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Respiratory Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781016/ https://www.ncbi.nlm.nih.gov/pubmed/29332840 http://dx.doi.org/10.1136/bmjopen-2017-018404

Ejemplares similares

Relationship between multimorbidity, demographic factors and mortality: findings from the UK Biobank cohort
por: Jani, Bhautesh Dinesh, et al.
Publicado: (2019)

Multimorbidity and co-morbidity in atrial fibrillation and effects on survival: findings from UK Biobank cohort
por: Jani, Bhautesh Dinesh, et al.
Publicado: (2018)

Risk Factors and Mortality Associated with Multimorbidity in People with Stroke or Transient Ischaemic Attack: A Study of 8,751 UK Biobank Participants
por: Gallacher, Katie I., et al.
Publicado: (2018)

Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participants
por: Hanlon, Peter, et al.
Publicado: (2018)

Association between childhood maltreatment and the prevalence and complexity of multimorbidity: A cross-sectional analysis of 157,357 UK Biobank participants
por: Hanlon, Peter, et al.
Publicado: (2020)

Prevalence of chronic pain in LTCs and multimorbidity: A cross-sectional study using UK Biobank
por: McQueenie, Ross, et al.
Publicado: (2021)

Patterns of multimorbidity and their effects on adverse outcomes in rheumatoid arthritis: a study of 5658 UK Biobank participants
por: McQueenie, Ross, et al.
Publicado: (2020)

Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort
por: McQueenie, Ross, et al.
Publicado: (2020)

Correction: Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort
por: McQueenie, Ross, et al.
Publicado: (2021)

Association between patterns of alcohol consumption (beverage type, frequency and consumption with food) and risk of adverse health outcomes: a prospective cohort study
por: Jani, Bhautesh Dinesh, et al.
Publicado: (2021)

Long-term conditions, multimorbidity and colorectal cancer risk in the UK Biobank cohort
por: Corcoran, Neave ME, et al.
Publicado: (2022)

Associations between multimorbidity and adverse health outcomes in UK Biobank and the SAIL Databank: A comparison of longitudinal cohort studies
por: Hanlon, Peter, et al.
Publicado: (2022)

An analysis of frailty and multimorbidity in 20,566 UK Biobank participants with type 2 diabetes
por: Hanlon, Peter, et al.
Publicado: (2021)

Multimorbidity and the risk of major adverse kidney events: findings from the UK Biobank cohort
por: Sullivan, Michael K, et al.
Publicado: (2021)

Frailty in COPD: an analysis of prevalence and clinical impact using UK Biobank
por: Hanlon, Peter, et al.
Publicado: (2022)

Examining the relationship between rheumatoid arthritis, multimorbidity and adverse health-related outcomes: A systematic review protocol
por: Canning, Jordan, et al.
Publicado: (2020)

Associations between long-term conditions and upper gastrointestinal cancer incidence: A prospective population-based cohort of UK Biobank participants
por: Marley, Jennifer, et al.
Publicado: (2021)

Classification of long-term condition patterns in rheumatoid arthritis and associations with adverse health events: a UK Biobank cohort study
por: McLoone, Philip, et al.
Publicado: (2023)

Frailty in rheumatoid arthritis and its relationship with disease activity, hospitalisation and mortality: a longitudinal analysis of the Scottish Early Rheumatoid Arthritis cohort and UK Biobank
por: Hanlon, Peter, et al.
Publicado: (2022)

Social connection and mortality in UK Biobank: a prospective cohort analysis
por: Foster, Hamish M. E., et al.
Publicado: (2023)

Multimorbidity, mortality, and HbA1c in type 2 diabetes: A cohort study with UK and Taiwanese cohorts
por: Chiang, Jason I., et al.
Publicado: (2020)

Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank
por: Niedzwiedz, Claire L., et al.
Publicado: (2020)

Chronic pain and COVID-19 hospitalisation and mortality: a UK Biobank cohort study
por: Hastie, Claire E., et al.
Publicado: (2023)

The presence and impact of multimorbidity clusters on adverse outcomes across the spectrum of kidney function
por: Sullivan, Michael K., et al.
Publicado: (2022)

Associations between multimorbidity, all-cause mortality and glycaemia in people with type 2 diabetes: A systematic review
por: Chiang, Jason I., et al.
Publicado: (2018)

Family history of diabetes and risk of SARS‐COV‐2 in UK Biobank: A prospective cohort study
por: Jani, Bhautesh Dinesh, et al.
Publicado: (2021)

Stroke, multimorbidity and polypharmacy in a nationally representative sample of 1,424,378 patients in Scotland: implications for treatment burden
por: Gallacher, Katie I, et al.
Publicado: (2014)

Associations between multimorbidity and glycaemia (HbA1c) in people with type 2 diabetes: cross-sectional study in Australian general practice
por: Chiang, Jason I, et al.
Publicado: (2020)

Hospitalisation events in people with chronic kidney disease as a component of multimorbidity: parallel cohort studies in research and routine care settings
por: Sullivan, Michael K., et al.
Publicado: (2021)

Associations between multimorbidity and adverse clinical outcomes in patients with chronic kidney disease: a systematic review and meta-analysis
por: Sullivan, Michael K., et al.
Publicado: (2020)

Challenges and Implications of Routine Depression Screening for Depression in Chronic Disease and Multimorbidity: A Cross Sectional Study
por: Jani, Bhautesh Dinesh, et al.
Publicado: (2013)

Impact of multimorbidity count on all-cause mortality and glycaemic outcomes in people with type 2 diabetes: a systematic review protocol
por: Chiang, Jason I, et al.
Publicado: (2018)

Comparison of two different frailty measurements and risk of hospitalisation or death from COVID-19: findings from UK Biobank
por: Petermann-Rocha, Fanny, et al.
Publicado: (2020)

Multimorbidity and the COVID-19 pandemic – An urgent call to action
por: Mair, Frances S, et al.
Publicado: (2020)

The association between a lifestyle score, socioeconomic status, and COVID-19 outcomes within the UK Biobank cohort
por: Foster, Hamish M. E., et al.
Publicado: (2022)

Feasibility trial of a digital self-management intervention ‘My Breathing Matters’ to improve asthma-related quality of life for UK primary care patients with asthma
por: Ainsworth, Ben, et al.
Publicado: (2019)

Comorbidity versus multimorbidity: Why it matters
por: Harrison, Christopher, et al.
Publicado: (2021)

Female reproductive history in relation to chronic obstructive pulmonary disease and lung function in UK biobank: a prospective population-based cohort study
por: Tang, Rosalind, et al.
Publicado: (2019)

Cumulative life course adversity, mental health, and cognition in the UK biobank
por: Künzi, M., et al.
Publicado: (2022)

Impact of omalizumab on treatment of severe allergic asthma in UK clinical practice: a UK multicentre observational study (the APEX II study)
por: Niven, Robert M, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9j99ld0gv4r4qmnjsafo8dn9i0